| 000 | 01704 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516130721.0 | ||
| 264 | 0 | _c20130423 | |
| 008 | 201304s 0 0 eng d | ||
| 022 | _a1532-1827 | ||
| 024 | 7 |
_a10.1038/bjc.2012.547 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aProvenzano, E | |
| 245 | 0 | 0 |
_aA central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cMar 2013 |
||
| 300 |
_a866-72 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aAxilla _xpathology |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymph Nodes _xpathology |
| 650 | 0 | 4 |
_aLymphatic Metastasis _xpathology |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 |
_aNeoplasm, Residual _xpathology |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aResearch Design _xstatistics & numerical data |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aVallier, A-L | |
| 700 | 1 | _aChamp, R | |
| 700 | 1 | _aWalland, K | |
| 700 | 1 | _aBowden, S | |
| 700 | 1 | _aGrier, A | |
| 700 | 1 | _aFenwick, N | |
| 700 | 1 | _aAbraham, J | |
| 700 | 1 | _aIddawela, M | |
| 700 | 1 | _aCaldas, C | |
| 700 | 1 | _aHiller, L | |
| 700 | 1 | _aDunn, J | |
| 700 | 1 | _aEarl, H M | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 108 _gno. 4 _gp. 866-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/bjc.2012.547 _zAvailable from publisher's website |
| 999 |
_c22402704 _d22402704 |
||